Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Lionsgate Studios Adopts Annual Say-on-Pay Vote Frequency

Lionsgate Studios Corp. filed a Form 8-K/A on November 6, 2026, amending its September 16, 2026 Current Report to disclose the company's decision to hold future advisory votes on executive compensation on an annual basis.

Vinay Lochav | 06 November 2026

Tokyo Lifestyle Calls Nov 30 EGM for Capital Reduction Vote

Tokyo Lifestyle Co., Ltd. filed a current report with the U.S. Securities and Exchange Commission on November 6, 2026, disclosing the convocation of an Extraordinary General Meeting of Shareholders scheduled for November 30, 2026, in Tokyo, Japan.

Nitish Kishor | 06 November 2026

Dutch Bros CLO Tullett to Retire, Druyan Named Successor

Dutch Bros Inc. filed a Form 8-K on November 6, 2026, disclosing that Chief Legal Officer Victoria Tullett notified the company on November 4, 2026 of her decision to retire in 2027, and that Kira Druyan has been appointed as the new Chief Legal …

Vinay Lochav | 06 November 2026

9F Inc. First Half 2026 Revenue Falls 48.3%

9F Inc. filed a Form 6-K with the SEC on November 6, 2026, reporting unaudited financial results for the six months ended June 30, 2026, disclosing a sharp decline in total net revenues alongside a large increase in net income driven by unrealized investment …

Shwetambri Chauhan | 06 November 2026

Knight-Swift Appoints Richard Howard to Board, Nov 2026

Knight-Swift Transportation Holdings Inc. filed an 8-K on November 6, 2026, disclosing the appointment of Richard Howard to its Board of Directors effective November 4, 2026, and the declaration of a quarterly cash dividend of $0.20 per share.

Aditi Sarkar | 06 November 2026

Fifth Era Acquisition Gets Nasdaq Extension to March 2027

Fifth Era Acquisition Corp I filed a Form 8-K on November 6, 2026, disclosing that Nasdaq granted the company an extension of time to regain compliance with the Minimum Total Holders Requirement after finding it deficient on September 14, 2026.

Vinay Lochav | 06 November 2026

InflaRx Publishes Phase 1 Izicopan Safety Data in 86 Participants

InflaRx N.V. filed a Form 6-K on November 6, 2026, reporting the peer-reviewed publication of first-in-human Phase 1 clinical data for its oral C5aR1 inhibitor izicopan, formerly known as INF904.

Manish Choudhary | 06 November 2026

Central Puerto Cancels 2,299,993 Treasury Shares by Law

Central Puerto S.A. filed a Form 6-K on November 6, 2026, disclosing the automatic cancellation of 2,299,993 treasury shares under Argentine Capital Markets Law No. 26,831, reducing the company's share capital to ARS 1,511,470,229.

Aditi Sarkar | 06 November 2026

Magnera Corp COO Manroa Vests 3,562 RSUs on Nov 4, 2026

Tarun Manroa, Executive Vice President and Chief Operating Officer of Magnera Corp, filed a Form 4 on November 6, 2026, disclosing the vesting of restricted stock units and a related tax-withholding transaction dated November 4, 2026.

Vinay Lochav | 06 November 2026

Pitofsky Exercises Options, Sells Shares on Nov 4, 2026

Jason Pitofsky, SVP Controller at Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), filed a Form 4 on November 6, 2026, disclosing option exercises and open-market sales of common stock that all occurred on November 4, 2026.

Manish Choudhary | 06 November 2026
Support

Hi! How can we help you today?

Loading…